BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
nitric oxide metabolic process
,
Pseudomonas infection
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FGFR 1
Summary
General Info
Curated Studies
Most Correlated Studies
Hearts from embryos treated with FGFR inhibitor SU5402
Mammary tumor gene expression profiles in MMTV-Wnt1 and MMTV-inducible FGFR bigenic mice
ESC-like cell populations derived from pluripotent epiblast stem cells
Embryonic stem cell (ESC)-like cells with Prdm14 knockout treated with LIF-containing serum
Heparan Sulfation Dependent FGF Signalling Maintains ES Cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoi…
The discovery of potent and stable short peptide FGFR1 antagonist for cancer therapy.
Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and…
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGF…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alte…
An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Recept…
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Gen…
HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid T…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ